Multiple Myeloma study: Cilta-cel
Official title A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
ClinicalTrials.gov ID: NCT05201781
What this study is testing
What is Cilta-cel?
This is an investigational cell therapy being studied for multiple myeloma. It is designed to use your own immune cells to target and attack cancer cells that have a specific marker called BCMA.
Also referred to as JNJ-68284528, LCAR-B38M CAR-T cells.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study will collect data on delayed side effects and describe the long‑term safety of cilta‑cel.
- Who it's for
- Participants with multiple myeloma who have previously been treated with cilta‑cel.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants who have received at least one dose of cilta-cel in a Company-sponsored clinical study
- Participants who have provided informed consent for this study
The study team makes the final eligibility decision.
Where it is enrolling
- Phoenix, Arizona, United States
- Duarte, California, United States
- San Francisco, California, United States
- Stanford, California, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Chicago, Illinois, United States
- Indianapolis, Indiana, United States
- Westwood, Kansas, United States
- Boston, Massachusetts, United States
- Detroit, Michigan, United States
- Rochester, Minnesota, United States
- St Louis, Missouri, United States
- Hackensack, New Jersey, United States
- New Brunswick, New Jersey, United States
- Buffalo, New York, United States
- New York, New York, United States
- The Bronx, New York, United States
- Charlotte, North Carolina, United States
- Philadelphia, Pennsylvania, United States
+ 13 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Phoenix, Arizona, United States; Duarte, California, United States; San Francisco, California, United States; Stanford, California, United States; Tampa, Florida, United States; Atlanta, Georgia, United States and 27 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.